Most Read Articles
3 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, 2 days ago
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
01 Apr 2020
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).
2 days ago
Cuff-based excess pressure (XSP) is modestly associated with carotid intima–media thickness independent of conventional risk factors, reveals a recent study.

DCH Auriga: New identity of LF Asia healthcare arm

18 Nov 2017

The launch of DCH Auriga marks the rebirth LF Asia healthcare business. Starting November 2017, the healthcare business under LF Asia is rebranded to DCH Auriga Ltd., while the consumer goods distribution operations are transferred to Integrated Market Services Asia Ltd.

“This restructuring will enable DCH Auriga to focus on better serving our strategic partners across the region and meet the unique and complex requirements of Asia’s healthcare communities,” according to Mr Tim Collins, CEO of DCH Auriga. “With the support of DCH and CITIC Pacific Limited, we are positioned for dynamic growth.”

The new corporate identity draws inspiration from “Auriga”, a constellation depicting a charioteer, which symbolizes the business’s commitment in guiding clients through complex and dynamic markets.

DCH Auriga provides treatments and healthcare solutions across Asia, with its footprint expanded across China, Hong Kong, Macau, Singapore, Malaysia, Thailand, Indonesia, and the Philippines. With partners in leading healthcare companies worldwide, DCH Auriga brings end-to-end solutions for clients including sales and marketing, commercial and logistic services, and regulatory and medical liaison support.

Currently, more than 500 brands of pharmaceuticals, medical devices, surgical equipment, diagnostics, and OTC products are under the distribution belt of the company and its partners.

Building on its established relationships with partners and local expertise, the company will continue to drive innovative solutions and insights to create optimized supply chains across Asia.  

DCH Auriga CEO, Mr Tim Collins
DCH Auriga CEO, Mr Tim Collins
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Tristan Manalac, 2 days ago
The coronavirus disease 2019 (COVID-19) appears to be more dangerous among cancer patients, who tend suffer more severe complications and faster disease progression, according to a new study.
01 Apr 2020
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).
2 days ago
Cuff-based excess pressure (XSP) is modestly associated with carotid intima–media thickness independent of conventional risk factors, reveals a recent study.